Arch Therapeutics, Inc. Quarterly Common Stock, Shares, Issued from Q3 2011 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Arch Therapeutics, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q3 2011 to Q2 2024.
  • Arch Therapeutics, Inc. Common Stock, Shares, Issued for the quarter ending June 30, 2024 was 4.44M shares, a 246% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 4.44M +3.16M +246% Jun 30, 2024 10-Q 2024-08-19
Q1 2024 4.44M +3.17M +249% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 4.74M +3.49M +279% Dec 31, 2023 10-Q 2024-02-20
Q3 2023 4.69M +3.44M +274% Sep 30, 2023 10-Q 2024-08-19
Q2 2023 1.29M -236M -99.5% Jun 30, 2023 10-Q 2023-08-11
Q1 2023 1.27M -236M -99.5% Mar 31, 2023 10-Q 2023-05-23
Q4 2022 1.25M -236M -99.5% Dec 31, 2022 10-Q 2023-02-14
Q3 2022 1.25M -236M -99.5% Sep 30, 2022 10-K 2024-02-15
Q2 2022 237M +450K +0.19% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 237M +450K +0.19% Mar 31, 2022 10-Q 2022-05-13
Q4 2021 237M +44.1M +22.8% Dec 31, 2021 10-Q 2022-02-11
Q3 2021 237M +44.1M +22.9% Sep 30, 2021 10-K 2022-12-28
Q2 2021 237M +41.1M +21% Jun 30, 2021 10-Q 2021-08-13
Q1 2021 237M +48.9M +26% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 193M +5.23M +2.79% Dec 31, 2020 10-Q 2021-02-12
Q3 2020 193M +19.5M +11.2% Sep 30, 2020 10-K 2021-12-17
Q2 2020 196M +22M +12.7% Jun 30, 2020 10-Q 2020-07-23
Q1 2020 188M +22.9M +13.9% Mar 31, 2020 10-Q 2020-05-05
Q4 2019 188M +22.9M +13.9% Dec 31, 2019 10-Q 2020-01-30
Q3 2019 174M +9.18M +5.58% Sep 30, 2019 10-K 2020-12-11
Q2 2019 174M +19.5M +12.7% Jun 30, 2019 10-Q 2019-08-01
Q1 2019 165M +10.9M +7.08% Mar 31, 2019 10-Q 2019-05-14
Q4 2018 165M +10.9M +7.08% Dec 31, 2018 10-Q 2019-02-01
Q3 2018 164M +10.7M +6.97% Sep 30, 2018 10-K 2019-11-19
Q2 2018 154M +3.28M +2.18% Jun 30, 2018 10-Q 2018-08-02
Q1 2018 154M +3.28M +2.18% Mar 31, 2018 10-Q 2018-04-26
Q4 2017 154M +15.9M +11.5% Dec 31, 2017 10-Q 2018-02-01
Q3 2017 154M +17M +12.5% Sep 30, 2017 10-K 2018-12-18
Q2 2017 151M +17.7M +13.3% Jun 30, 2017 10-Q 2017-07-27
Q1 2017 151M +40.3M +36.5% Mar 31, 2017 10-Q 2017-05-02
Q4 2016 138M +29M +26.6% Dec 31, 2016 10-Q 2017-02-01
Q3 2016 137M +29.1M +27% Sep 30, 2016 10-K 2017-11-15
Q2 2016 133M +40.3M +43.5% Jun 30, 2016 10-Q 2016-07-28
Q1 2016 110M +34.3M +45.1% Mar 31, 2016 10-Q 2016-04-28
Q4 2015 109M +33.1M +43.5% Dec 31, 2015 10-Q 2016-02-12
Q3 2015 108M +35.5M +49.3% Sep 30, 2015 10-K 2016-12-05
Q2 2015 92.7M +20.6M +28.6% Jun 30, 2015 10-Q 2015-08-07
Q1 2015 76.1M +4M +5.55% Mar 31, 2015 10-Q 2015-05-07
Q4 2014 76.1M +15.9M +26.5% Dec 31, 2014 10-Q 2015-02-09
Q3 2014 72.1M +11.9M +19.8% Sep 30, 2014 10-K 2015-12-11
Q2 2014 72.1M +13.4M +22.9% Jun 30, 2014 10-Q 2014-08-06
Q1 2014 72.1M +66M +1095% Mar 31, 2014 10-Q 2014-05-15
Q4 2013 60.1M +54.1M +897% Dec 31, 2013 10-Q 2014-02-14
Q3 2013 60.1M +54.5M +965% Sep 30, 2013 10-K 2014-12-12
Q2 2013 58.6M +52.6M +873% Jun 30, 2013 10-Q 2013-08-14
Q1 2013 6.03M Mar 31, 2013 10-Q 2013-05-20
Q4 2012 6.03M Dec 31, 2012 10-Q 2013-02-14
Q3 2012 5.65M +1.65M +41.1% Sep 30, 2012 10-K/A 2014-05-01
Q2 2012 6.03M Jun 30, 2012 10-Q 2012-08-14
Q3 2011 4M Sep 30, 2011 10-K 2012-12-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.